Qiagen N.V. (QGEN): Price and Financial Metrics


Qiagen N.V. (QGEN): $41.47

0.25 (+0.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QGEN POWR Grades

  • QGEN scores best on the Quality dimension, with a Quality rank ahead of 91.27% of US stocks.
  • The strongest trend for QGEN is in Growth, which has been heading down over the past 177 days.
  • QGEN's current lowest rank is in the Momentum metric (where it is better than 6.37% of US stocks).

QGEN Stock Summary

  • With a market capitalization of $9,326,346,240, QIAGEN NV has a greater market value than 84.1% of US stocks.
  • With a one year PEG ratio of 451.88, QIAGEN NV is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.71% of US stocks.
  • The volatility of QIAGEN NV's share price is greater than that of just 6.96% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to QGEN, based on their financial statements, market capitalization, and price volatility, are FOXF, HOLX, FCEL, LOGI, and IRIX.
  • QGEN's SEC filings can be seen here. And to visit QIAGEN NV's official web site, go to www.qiagen.com.

QGEN Valuation Summary

  • In comparison to the median Healthcare stock, QGEN's EV/EBIT ratio is 98.75% higher, now standing at 15.9.
  • QGEN's price/sales ratio has moved up 1.7 over the prior 243 months.

Below are key valuation metrics over time for QGEN.

Stock Date P/S P/B P/E EV/EBIT
QGEN 2022-09-23 4.2 2.9 18.3 15.9
QGEN 2022-09-22 4.2 2.9 18.5 16.1
QGEN 2022-09-21 4.3 2.9 18.8 16.3
QGEN 2022-09-20 4.4 3.0 19.2 16.6
QGEN 2022-09-19 4.4 3.0 19.3 16.7
QGEN 2022-09-16 4.4 3.0 19.2 16.6

QGEN Growth Metrics

    Its year over year net income to common stockholders growth rate is now at 20.09%.
  • Its 5 year revenue growth rate is now at 17.41%.
  • Its 3 year revenue growth rate is now at 53.48%.
Over the past 15 months, QGEN's revenue has gone up $195,591,000.

The table below shows QGEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 2,261.046 733.338 514.298
2022-03-31 2,312.842 717.784 538.688
2022-03-31 2,312.842 717.374 538.688
2021-12-31 2,251.657 639.001 512.599
2021-12-31 2,251.657 NA 512.599
2021-09-30 2,240.493 710.255 596.098

QGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QGEN has a Quality Grade of B, ranking ahead of 79.35% of graded US stocks.
  • QGEN's asset turnover comes in at 0.375 -- ranking 125th of 682 Pharmaceutical Products stocks.
  • ALNY, TXMD, and CASI are the stocks whose asset turnover ratios are most correlated with QGEN.

The table below shows QGEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.375 0.655 0.192
2021-03-31 0.363 0.658 0.199
2020-12-31 0.338 0.659 0.176
2020-12-31 0.338 0.659 0.176
2020-09-30 0.319 0.665 0.122
2020-09-30 0.319 0.665 0.122

QGEN Stock Price Chart Interactive Chart >

Price chart for QGEN

QGEN Price/Volume Stats

Current price $41.47 52-week high $58.00
Prev. close $41.22 52-week low $40.49
Day low $41.39 Volume 471,564
Day high $42.30 Avg. volume 842,944
50-day MA $46.35 Dividend yield N/A
200-day MA $47.59 Market Cap 9.42B

Qiagen N.V. (QGEN) Company Bio


QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.


QGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

QGEN Latest Social Stream


Loading social stream, please wait...

View Full QGEN Social Stream

Latest QGEN News From Around the Web

Below are the latest news stories about QIAGEN NV that investors may wish to consider to help them evaluate QGEN as an investment opportunity.

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors are optimistic about QIAGEN's (QGEN) better-than-expected results and solid genomics uptake.

Yahoo | September 22, 2022

QIAGEN (QGEN) Assays to Detect Organ Transplant-Related Viruses

QIAGEN's (QGEN) latest additions to the NeuMoDx assay menu will help identify EBV and HHV-6 viruses in immunocompromised patients.

Yahoo | September 19, 2022

IGI Inex Holding (UK) Becomes Strategic Investor in Quantumrock, Cementing Partnership Between Leading Global Investment Group and AI Asset Tech Frontrunners

London-based privately-owned global investment company, IGI Inex Holding, today announces it has become a strategic investor in artificial intelligence (AI) and machine learning (ML) leaders, Munich-based AI asset and portfolio management company, quantumrock.

Yahoo | September 16, 2022

QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System

HILDEN, Germany & GERMANTOWN, Md., September 15, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to its comprehensive NeuMoDx assay menu for organ transplant-associated viruses. The new assays for the identification and quantification of the Epstein-Barr virus (EBV) and the human herpesvirus 6 (HHV-6) have received CE-IVD certification for the European Union and other countries that accept this marking.

Yahoo | September 15, 2022

QIAGEN (QGEN) to Develop Companion Diagnostic for Neuron23

QIAGEN's (QGEN) novel companion diagnostic assay will help identify individuals who might benefit from Neuron23's drug candidate for Parkinson's disease.

Yahoo | September 15, 2022

Read More 'QGEN' Stories Here

QGEN Price Returns

1-mo -8.72%
3-mo -13.33%
6-mo -16.05%
1-year -19.76%
3-year 29.84%
5-year 31.65%
YTD -25.39%
2021 5.17%
2020 56.36%
2019 -1.89%
2018 11.38%
2017 6.30%

Continue Researching QGEN

Here are a few links from around the web to help you further your research on Qiagen Nv's stock as an investment opportunity:

Qiagen Nv (QGEN) Stock Price | Nasdaq
Qiagen Nv (QGEN) Stock Quote, History and News - Yahoo Finance
Qiagen Nv (QGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4698 seconds.